SFG
SevenBridge Financial Group Portfolio holdings
AUM
$508M
This Quarter Return
+7.54%
1 Year Return
+7.92%
3 Year Return
+29.43%
5 Year Return
+135.77%
10 Year Return
–
AUM
$307M
AUM Growth
+$307M
(+12%)
Cap. Flow
+$13.8M
Cap. Flow
% of AUM
4.51%
Top 10 Holdings %
Top 10 Hldgs %
32.64%
Holding
166
New
11
Increased
112
Reduced
20
Closed
3
Top Buys
| 1 |
NVTA
Invitae Corporation
NVTA
|
$1.55M |
| 2 |
Fate Therapeutics
FATE
|
$1.17M |
| 3 |
Sherwin-Williams
SHW
|
$727K |
| 4 |
Intel
INTC
|
$681K |
| 5 |
Amazon
AMZN
|
$540K |
Top Sells
| 1 |
BioNTech
BNTX
|
$2.03M |
| 2 |
Under Armour
UAA
|
$717K |
| 3 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
$269K |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
$55.6K |
| 5 |
Lam Research
LRCX
|
$46.2K |
Sector Composition
| 1 | Technology | 20.91% |
| 2 | Healthcare | 13.77% |
| 3 | Consumer Staples | 11.35% |
| 4 | Communication Services | 9.92% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Illinois Tool Works
ITW
$76.4B
| $344K | 0.11% |
1,539
+18
| +1% | +$4.02K |
|
127
Enbridge
ENB
$105B
| $336K | 0.11% |
+8,381
| New | +$336K |
|
128
Paychex
PAYX
$49B
| $334K | 0.11% |
3,110
+56
| +2% | +$6.01K |
|
129
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
$408M
| $329K | 0.11% |
21,764
| – | – |
|
130
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.28B
| $317K | 0.1% |
20,205
| – | – |
|
131
Progressive
PGR
$144B
| $314K | 0.1% |
3,201
-25
| -0.8% | -$2.45K |
|
132
Automatic Data Processing
ADP
$121B
| $313K | 0.1% |
1,578
+49
| +3% | +$9.72K |
|
133
VF Corp
VFC
$5.8B
| $310K | 0.1% |
3,784
-49
| -1% | -$4.01K |
|
134
Invesco Pennsylvania Value Municipal Income Trust
VPV
$179M
| $310K | 0.1% |
23,200
| – | – |
|
135
Philip Morris
PM
$261B
| $304K | 0.1% |
3,069
+26
| +0.9% | +$2.58K |
|
136
Aflac
AFL
$56.5B
| $300K | 0.1% |
5,594
| – | – |
|
137
Global X Silver Miners ETF NEW
SIL
$2.84B
| $296K | 0.1% |
+6,928
| New | +$296K |
|
138
Brown-Forman Class B
BF.B
$13.8B
| $291K | 0.09% |
3,879
| – | – |
|
139
Invesco QQQ Trust
QQQ
$361B
| $289K | 0.09% |
+816
| New | +$289K |
|
140
Colgate-Palmolive
CL
$68.2B
| $287K | 0.09% |
3,526
| – | – |
|
141
Stryker
SYK
$149B
| $282K | 0.09% |
1,087
+36
| +3% | +$9.34K |
|
142
Editas Medicine
EDIT
$222M
| $274K | 0.09% |
4,842
| – | – |
|
143
Elevance Health
ELV
$72.6B
| $272K | 0.09% |
712
| – | – |
|
144
Clorox
CLX
$14.7B
| $271K | 0.09% |
1,507
| – | – |
|
145
Schlumberger
SLB
$53.6B
| $268K | 0.09% |
8,363
+180
| +2% | +$5.77K |
|
146
Blackrock
BLK
$173B
| $265K | 0.09% |
302
+32
| +12% | +$28.1K |
|
147
Brown & Brown
BRO
$31.5B
| $265K | 0.09% |
4,978
| – | – |
|
148
Kellanova
K
$27.4B
| $257K | 0.08% |
3,998
+368
| +10% | +$23.7K |
|
149
GSK
GSK
$78.5B
| $255K | 0.08% |
6,414
-600
| -9% | -$23.9K |
|
150
Trane Technologies
TT
$91.4B
| $246K | 0.08% |
1,336
+5
| +0.4% | +$921 |
|